Suppr超能文献

直接经皮内镜下空肠造口术的长期预后:一项10年队列研究

Long-term outcomes of direct percutaneous endoscopic jejunostomy: a 10-year cohort.

作者信息

Lim Amanda H, Schoeman Mark N, Nguyen Nam Q

机构信息

Departments of Gastroenterology and Hepatology, Royal Adelaide Hospital, Adelaide, Australia.

Departments of Gastroenterology and Hepatology, Royal Adelaide Hospital, Adelaide, Australia ; University Department of Medicine, University of Adelaide, Royal Adelaide Hospital, Adelaide, Australia.

出版信息

Endosc Int Open. 2015 Dec;3(6):E610-4. doi: 10.1055/s-0034-1392806. Epub 2015 Sep 15.

Abstract

STUDY AIM

To assess the clinical outcomes of patients who received direct percutaneous endoscopic jejunostomy (DPEJ) for enteral feeding.

MATERIALS AND METHODS

This is a 10-year cohort study in a single tertiary center. Main outcome measurements were technical success, and short- and long-term outcomes. DPEJ was attempted in 83 patients (51 men; 55 ± 2 years) for dysphagia (n = 35), gastroparesis with recurrent aspiration (n = 30), and levodopa drug infusion for severe Parkinson's disease (n = 18).

RESULTS

DPEJ was successful in 75 (90 %) patients. All technical failures were related to the inability to find adequate trans-illumination, and were not influenced by BMI, age, gender, or indication. Peri-operative (30-day) adverse events occurred in 11 (13 %) patients, including wound infection (3), leakage around the stoma (4), minor bleeding requiring no intervention (2), and aspiration (1). There was one case (1.2 %) of gastric perforation after PEJ insertion for levodopa drug infusion trial. This 60-year-old woman required an emergency laparotomy with nil complications, and levodopa drug infusion recommenced successfully. One case of intestinal perforation (1.2 %) occurred after jejunostomy tube replacement at 6 months of insertion, which was successfully managed with surgery. There were no peri-operative deaths. Adequate delivery of enteral feeding or Duodopa drug was achieved in 66/73 (90 %) patients, with evidence of weight gain or improvement in Parkinson's disease. Seven (8 %) continued to have clinical regurgitation but not aspiration. After a median follow-up of 84 months, 27 (33 %) patients died of their underlying diseases. Seven (8 %) had marked improvement in their underlying disease and had PEJ removed after 5 months (range 1 - 8 months).

LIMITATIONS

Single center study.

CONCLUSIONS

DPEJ is associated with a high technical success rate (90 %), a relatively low rate of peri-operative adverse events (13 %) and an improvement in long-term nutritional support in the majority of patients (90 %). DPEJ should be the procedure of choice to gain enteral access for feeding or drug delivery prior to considering surgery.

摘要

研究目的

评估接受直接经皮内镜空肠造口术(DPEJ)进行肠内营养支持的患者的临床结局。

材料与方法

这是一项在单一三级中心开展的为期10年的队列研究。主要结局指标为技术成功率以及短期和长期结局。83例患者(51例男性;年龄55±2岁)接受了DPEJ,其中吞咽困难患者35例,反复误吸的胃轻瘫患者30例,严重帕金森病患者18例(接受左旋多巴药物输注)。

结果

75例(90%)患者DPEJ成功。所有技术失败均与无法找到足够的透照有关,且不受体重指数、年龄、性别或适应证的影响。围手术期(30天)不良事件发生在11例(13%)患者中,包括伤口感染3例、造口周围渗漏4例、无需干预的少量出血2例、误吸1例。在左旋多巴药物输注试验的PEJ置入后发生1例胃穿孔(1.2%)。这名60岁女性需要进行急诊剖腹手术,无并发症发生,左旋多巴药物输注成功重新开始。1例肠穿孔(1.2%)发生在空肠造口管置入6个月后更换时,通过手术成功处理。无围手术期死亡病例。66/73例(90%)患者实现了充足的肠内营养或Duodopa药物输注,有体重增加或帕金森病改善的证据。7例(8%)患者持续存在临床反流但无误吸。中位随访8个月后,27例(33%)患者死于基础疾病。7例(8%)患者基础疾病明显改善,5个月(范围1 - 8个月)后拔除了PEJ。

局限性

单中心研究。

结论

DPEJ技术成功率高(90%),围手术期不良事件发生率相对较低(13%),且大多数患者(90%)长期营养支持得到改善。在考虑手术之前,DPEJ应作为获取肠内营养通路进行喂养或给药的首选方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eaa/4683153/63d62b81ee98/10-1055-s-0034-1392806-i191ei1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验